Jodas Expoim
Pharmaceutical companies
Since 2009
Russia
Central Federal District of the Russian Federation
Moscow
109651, Pererva St., 11, building 25
For August, 2019 a core activity is production of pharmaceutical substances.
2019: The Supreme Court supported an originator in a dispute with generic on protection of the patent
On August 16, 2019 it became known that the Supreme Court of the Russian Federation (Russian Armed Forces) permitted for benefit of Astrazeneka company a dispute with Dzhodas Expoim on protection of the exclusive rights to reference antineoplastic medicine gefitinib. The Supreme Court refused Dzhodas Expoim transfer of the writ of appeal for consideration in court session of Judicial board on economic disputes of Russian Armed Forces, having upheld judicial acts which oblige to withdraw Dzhodas Expoim the registration certificate and the price of generic and also prohibit to file Dzhodas Expoim documents for repeated registration of generic before expiration of the patent for reference medicine. Read more here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |